Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Meyer

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Respiratory Care|November 12, 2002
Bringing new nebulizer technologies to market: regulatory issuesRobert J Meyer
Diabetes Care|December 8, 2016
Precision Medicine, Diabetes, and the U.S. Food and Drug AdministrationRobert J Meyer
Clinical and Translational Science|September 19, 2020
Priority Review Vouchers: GAO Report Provides Scant Evidence of SuccessRobert J Meyer
The New England Journal of Medicine|August 28, 2014
Evolocumab in hyperlipidemiaRobert J Meyer
COPD|December 2, 2006
U.S. regulatory perspective on the minimal clinically important difference in chronic obstructive pulmonary diseaseRobert J Meyer
The New England Journal of Medicine|March 17, 2017
Short-Term versus Long-Term Blood StorageRobert J Meyer
Annals of Emergency Medicine|March 27, 2003
FDA "black box" labelingRobert J Meyer
Respiratory Care|May 26, 2018
Drug Development for Asthma and COPD: A Regulatory PerspectiveMarianne Mann, Robert J Meyer
Current Medical Research and Opinion|February 18, 2015
Pulmonary oil micro-embolism (POME) syndrome: a review and summary of a large case seriesRobert J Meyer, Marianne Mann
The New England Journal of Medicine|March 30, 2007
Withdrawal of albuterol inhalers containing chlorofluorocarbon propellantsLeslie Hendeles, Gene L Colice, Robert J Meyer
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Respiratory Care|November 12, 2002
Bringing new nebulizer technologies to market: regulatory issuesRobert J Meyer
Diabetes Care|December 8, 2016
Precision Medicine, Diabetes, and the U.S. Food and Drug AdministrationRobert J Meyer
Clinical and Translational Science|September 19, 2020
Priority Review Vouchers: GAO Report Provides Scant Evidence of SuccessRobert J Meyer
The New England Journal of Medicine|August 28, 2014
Evolocumab in hyperlipidemiaRobert J Meyer
COPD|December 2, 2006
U.S. regulatory perspective on the minimal clinically important difference in chronic obstructive pulmonary diseaseRobert J Meyer
The New England Journal of Medicine|March 17, 2017
Short-Term versus Long-Term Blood StorageRobert J Meyer
Annals of Emergency Medicine|March 27, 2003
FDA "black box" labelingRobert J Meyer
Respiratory Care|May 26, 2018
Drug Development for Asthma and COPD: A Regulatory PerspectiveMarianne Mann, Robert J Meyer
Current Medical Research and Opinion|February 18, 2015
Pulmonary oil micro-embolism (POME) syndrome: a review and summary of a large case seriesRobert J Meyer, Marianne Mann
The New England Journal of Medicine|March 30, 2007
Withdrawal of albuterol inhalers containing chlorofluorocarbon propellantsLeslie Hendeles, Gene L Colice, Robert J Meyer
Pageof 2